CARDIZEM Drug Patent Profile
✉ Email this page to a colleague
When do Cardizem patents expire, and what generic alternatives are available?
Cardizem is a drug marketed by Biovail, Biovail Labs Intl, and Bausch. and is included in six NDAs.
The generic ingredient in CARDIZEM is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cardizem
A generic version of CARDIZEM was approved as diltiazem hydrochloride by TEVA on May 31st, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARDIZEM?
- What are the global sales for CARDIZEM?
- What is Average Wholesale Price for CARDIZEM?
Summary for CARDIZEM
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 58 |
Clinical Trials: | 10 |
Patent Applications: | 2,997 |
Drug Prices: | Drug price information for CARDIZEM |
What excipients (inactive ingredients) are in CARDIZEM? | CARDIZEM excipients list |
DailyMed Link: | CARDIZEM at DailyMed |
Recent Clinical Trials for CARDIZEM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | Early Phase 1 |
CAMC Health System | Phase 4 |
University of South Florida | N/A |
Pharmacology for CARDIZEM
Drug Class | Calcium Channel Blocker |
Mechanism of Action | Calcium Channel Antagonists |
US Patents and Regulatory Information for CARDIZEM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biovail | CARDIZEM | diltiazem hydrochloride | INJECTABLE;INJECTION | 020792-001 | Sep 5, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bausch | CARDIZEM LA | diltiazem hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021392-006 | Feb 6, 2003 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Bausch | CARDIZEM | diltiazem hydrochloride | TABLET;ORAL | 018602-004 | Dec 8, 1986 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Bausch | CARDIZEM | diltiazem hydrochloride | TABLET;ORAL | 018602-001 | Nov 5, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CARDIZEM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | CARDIZEM | diltiazem hydrochloride | TABLET;ORAL | 018602-001 | Nov 5, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | CARDIZEM | diltiazem hydrochloride | TABLET;ORAL | 018602-004 | Dec 8, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | CARDIZEM | diltiazem hydrochloride | TABLET;ORAL | 018602-004 | Dec 8, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | CARDIZEM | diltiazem hydrochloride | TABLET;ORAL | 018602-004 | Dec 8, 1986 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CARDIZEM
See the table below for patents covering CARDIZEM around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
United Kingdom | 1236467 | ⤷ Sign Up | |
Sweden | 339531 | ⤷ Sign Up | |
United Kingdom | 1040544 | ⤷ Sign Up | |
Denmark | 131462 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |